Understanding Kearns-Sayre Syndrome
Kearns-Sayre Syndrome is a type of neuromuscular disorder that is characterized by a deletion in mitochondrial DNA. While it primarily affects the eyes, symptoms of this syndrome typically manifest before the age of 20. One of the key signs of Kearns-Sayre Syndrome is progressive external ophthalmoplegia, which refers to the weakness or paralysis of the muscles that control eye movement.
In addition to ophthalmoplegia, individuals with Kearns-Sayre Syndrome may also develop a condition known as pigmentary retinopathy. This condition causes the retina to exhibit a speckled or streaked appearance, ultimately leading to retinal degeneration and potential vision loss. The presence of excess mitochondria in muscle cells is a distinctive characteristic of this syndrome.
It is important to note that a related condition called ophthalmoplegia-plus exists, which shares similarities with Kearns-Sayre Syndrome but may not fully meet all the diagnostic criteria. In such cases, medical professionals may opt to diagnose the patient with ophthalmoplegia-plus instead.
Tolosa Hunt Syndrome
Tolosa Hunt Syndrome was first identified by a Spanish neurosurgeon in 1954. This rare disorder is often triggered by traumatic injury, tumors, or aneurysms. The primary symptom is sharp, intense pain accompanied by ophthalmoplegia, typically affecting one eye. Headaches in the tissues surrounding the eye socket are also common. Other possible symptoms include decreased eye movements, ptosis (drooping eyelid), diplopia (double vision), an enlarged pupil, protrusion of the eye, and facial numbness. In severe cases, the affected eye may lose its ability to move in different directions. Fortunately, symptoms of Tolosa Hunt Syndrome typically resolve on their own without any intervention or with the use of steroid drugs.